Description
BML-277 (Chk2 Inhibitor II) is an arylbenzimidazole inhibitor of checkpoint kinase (CHK) 2. This compound displays cytoprotective activity, protecting CD4+ and CD8+ T cells against radiation-induced apoptosis.
| Product Unit Size | Cost | Quantity | Stock |
|---|
BML-277 (Chk2 Inhibitor II) is an arylbenzimidazole inhibitor of checkpoint kinase (CHK) 2. This compound displays cytoprotective activity, protecting CD4+ and CD8+ T cells against radiation-induced apoptosis.
| Cas No. | 516480-79-8 |
|---|---|
| Purity | ≥98% |
| Formula | C20H14ClN3O2 |
| Formula Wt. | 363.80 |
| Chemical Name | 2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-5-carboxamide |
| IUPAC Name | 2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-5-carboxamide |
| Synonym | Chk2 Inhibitor II |
| Solubility | DMSO 72 mg/mL Ethanol 21 mg/mL Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Arienti KL, Brunmark A, Axe FU, et al. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem. 2005 Mar 24;48(6):1873-85. PMID: 15771432.
Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...
Flavonol found in fruits and vegetables; COMT i...
Endogenous peptide hormone, involved in feeding...
Triterpene saponin originally found in Bolboste...
Endogenous peptide hormone, involved in intesti...
Proteasome inhibitor.
Non-selective cannabinoid receptor agonist.
Protease substrate.
AMPK activator.
Found in Taxus, starting material for synthesis...
Stilbenoid glucoside found in Polygonum.
GSK-3β, HGK, and CDK inhibitor.
PDGFR inhibitor.
FIASMA, SERT inhibitor, 5-HT and σ1 antagonist...
Retinoid, differentiation inducer.
5-HT7 and D2/3 antagonist.
Effective against gram-positive pathogens
EGFR2 inhibitor.
PKC and S6 kinase substrate.
Endogenous amino acid sugar involved in cartila...